We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSG icon
3326
iShares S&P GSCI Commodity-Indexed Trust
GSG
$900M
$3.06M ﹤0.01%
138,354
+66,445
+92% +$1.48M
BGS icon
3327
B&G Foods
BGS
$286M
$3.06M ﹤0.01%
378,926
+76,214
+25% +$752K
DFE icon
3328
WisdomTree Europe SmallCap Dividend Fund
DFE
$169M
$3.06M ﹤0.01%
51,306
-58,488
-53% -$3.56M
MGNI icon
3329
Magnite
MGNI
$3.55B
$3.05M ﹤0.01%
229,510
+74,071
+48% +$810K
LIND icon
3330
Lindblad Expeditions
LIND
$2.22B
$3.05M ﹤0.01%
316,001
+65,769
+26% +$509K
MAIN icon
3331
Main Street Capital
MAIN
$5.48B
$3.05M ﹤0.01%
60,368
+3,214
+6% +$157K
EGO icon
3332
CALL
Eldorado Gold
EGO
$9.89B
$3.05M ﹤0.01%
+206,000
New +$3.12M
AMX icon
3333
America Movil
AMX
$71.2B
$3.04M ﹤0.01%
179,009
+79,853
+81% +$1.47M
BNL icon
3334
Broadstone Net Lease
BNL
$4.02B
$3.03M ﹤0.01%
191,234
-148,620
-44% -$2.25M
SYF icon
3335
CALL
Synchrony
SYF
$25.6B
$3.03M ﹤0.01%
64,300
GATX icon
3336
GATX Corp
GATX
$6.27B
$3.03M ﹤0.01%
22,912
-25,504
-53% -$3.36M
MFIC icon
3337
MidCap Financial Investment
MFIC
$804M
$3.03M ﹤0.01%
200,246
+20,748
+12% +$318K
MT icon
3338
ArcelorMittal
MT
$55.3B
$3.03M ﹤0.01%
132,065
+80,019
+154% +$2.05M
CSA
3339
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
$3.02M ﹤0.01%
44,828
+951
+2% +$63.9K
AS icon
3340
Amer Sports
AS
$21.4B
$3.02M ﹤0.01%
240,222
+237,049
+7,471% +$3.48M
UITB icon
3341
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.65B
$3.02M ﹤0.01%
65,611
+13,798
+27% +$632K
IRTC icon
3342
PUT
iRhythm Holdings
IRTC
$4.2B
$3.01M ﹤0.01%
28,000
CXE
3343
DELISTED
MFS High Income Municipal Trust
CXE
$3.01M ﹤0.01%
811,831
+14,554
+2% +$52.2K
HL icon
3344
Hecla Mining
HL
$11.3B
$3M ﹤0.01%
619,366
-393,612
-39% -$2.1M
PJP icon
3345
Invesco Pharmaceuticals ETF
PJP
$498M
$3M ﹤0.01%
36,513
-2,587
-7% -$206K
VRDN icon
3346
Viridian Therapeutics
VRDN
$2.67B
$3M ﹤0.01%
230,376
-149,208
-39% -$2.07M
KROS icon
3347
Keros Therapeutics
KROS
$221M
$3M ﹤0.01%
65,555
-58,630
-47% -$3.15M
GRC icon
3348
Gorman-Rupp
GRC
$2.21B
$2.99M ﹤0.01%
81,551
-20,637
-20% -$729K
WLK icon
3349
Westlake Corp
WLK
$9.9B
$2.99M ﹤0.01%
20,670
-11,576
-36% -$1.78M
TR icon
3350
Tootsie Roll Industries
TR
$2.98B
$2.99M ﹤0.01%
103,822
-1,443
-1% -$40.7K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.